[ad_1] A monthly vaginal ring that slowly releases an antiretroviral drug (ARV) called dapivirine is undergoing regulatory review. If approved, the dapivirine ring would be the first method of biomedical HIV prevention …
Read More »Sensitive tests suggest a low risk of drug resistance with the dapivirine ring
